Related Experiment Video
Updated: Feb 13, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
MicroRNA-374b-5p suppresses osteosarcoma progression via the PDPK1-mediated AKT pathway
Yong Xi1,2, Zhengyi Sun1, Jingbin Wu1
1Department of Orthopedics, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, China.
Background:
MicroRNAs (miRNAs) have been verified to be involved in various biological processes through regulating their target genes, and some previous studies have revealed the antitumour role of microRNA-374b-5p (miR-374b-5p) in several tumours. Therefore, the purpose of this study was to explore the functions and potential mechanisms of miR-374b-5p in osteosarcoma (OS) progression.
Methods:
The differentially expressed gene miR-374b-5p was discovered in the dataset GSE65071 from the Gene Expression Omnibus (GEO) database via bioinformatics analysis, and its expression levels in OS tissues and cell lines were confirmed by RNA fluorescence in situ hybridization (FISH) staining and quantitative real-time polymerase chain reaction (qRT-PCR). OS cell proliferation ability was evaluated by Cell Counting Kit-8 (CCK-8) assay and colony formation assay, cell migration and invasion abilities were assessed by Transwell assays, and apoptosis was detected by flow cytometry. The underlying mechanisms of miR-374b-5p in regulating OS progression were explored by qRT-PCR, dual-luciferase reporter assay and western blotting. In vivo experiments, a nude mice xenograft tumour model was performed to evaluate the effects of miR-374b-5p on tumour growth and gene expression changes.
Results:
In this study, miR-374b-5p expression was confirmed to be significantly down-regulated in OS, and miR-374b-5p overexpression could inhibit the proliferation, migration, and invasion abilities but promote apoptosis of OS cells. Mechanism studies revealed that miR-374b-5p suppressed the AKT pathway via negatively regulating the expression of phosphoinositide-dependent protein kinase 1 (PDPK1). Notably, PDPK1 were highly expressed in OS cell lines, as verified by qRT-PCR, and PDPK1-silencing considerably restrained OS progression. Moreover, the inhibitory effects of miR-374b-5p on OS progression were partially reversed by PDPK1 overexpression both in vitro and in vivo.
Conclusions:
MiR-374b-5p was lowly expressed in OS, and its upregulation inhibited the progression of OS by directly targeting PDPK1 to affect the activity of the AKT pathway.
Insights
MicroRNA-374b-5p (miR-374b-5p) is downregulated in osteosarcoma (OS). Upregulating miR-374b-5p inhibits OS progression by targeting PDPK1 and suppressing the AKT pathway.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- MicroRNAs (miRNAs) regulate gene expression and are implicated in various biological processes.
- Previous research suggests a potential anti-tumor role for microRNA-374b-5p (miR-374b-5p) in several cancers.
- Osteosarcoma (OS) is a primary bone malignancy with complex molecular underpinnings.
Purpose of the Study:
- To investigate the functional role of miR-374b-5p in osteosarcoma (OS) progression.
- To elucidate the underlying molecular mechanisms by which miR-374b-5p influences OS development.
- To assess the therapeutic potential of targeting miR-374b-5p in osteosarcoma.
Main Methods:
- Bioinformatic analysis of the GSE65071 dataset (GEO database) to identify differentially expressed miRNAs.
- Validation of miR-374b-5p expression in OS tissues and cell lines using qRT-PCR and FISH.
- In vitro assays including CCK-8, colony formation, Transwell, and flow cytometry to evaluate OS cell proliferation, migration, invasion, and apoptosis.
- Mechanism studies involving qRT-PCR, dual-luciferase reporter assay, and western blotting.
- In vivo evaluation using a nude mice xenograft tumor model.
Main Results:
- miR-374b-5p expression was significantly downregulated in osteosarcoma (OS) tissues and cell lines.
- Overexpression of miR-374b-5p inhibited OS cell proliferation, migration, and invasion, while promoting apoptosis.
- Mechanism studies revealed that miR-374b-5p directly targets phosphoinositide-dependent protein kinase 1 (PDPK1), suppressing the AKT signaling pathway.
- PDPK1 was highly expressed in OS and its silencing inhibited OS progression.
- Overexpression of PDPK1 partially reversed the inhibitory effects of miR-374b-5p on OS progression both in vitro and in vivo.
Conclusions:
- miR-374b-5p acts as a tumor suppressor in osteosarcoma (OS).
- The upregulation of miR-374b-5p inhibits OS progression by directly targeting PDPK1 and modulating the AKT pathway.
- miR-374b-5p represents a potential therapeutic target for osteosarcoma treatment.
More Related Videos
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
MicroRNAs
MicroRNAs
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...